SCHEMBL6286761

SCHEMBL6286761

Cc1[nH]c2ccccc2c1CC(=O)NC(C)C(=O)Nc1ccc(C(c2ccc(NC(=O)C(C)NC(=O)Cc3c(C)[nH]c4ccccc34)cc2)c2ccc(NC(=O)C(C)NC(=O)Cc3c(C)[nH]c4ccccc34)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 2/20 0.49
GAA P10253 2/20 0.49
CASP1 P29466 2/20 0.49
MAPT P10636 1/20 0.49
CASP7 P55210 1/20 0.49
HDAC1 Q13547 6/20 0.45
KLK6 Q92876 2/20 0.45
ESR1 P03372 4/20 0.43
ESR2 Q92731 4/20 0.43
NTRK1 P04629 1/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PABPC1 P11940 1/20 0.40
ALOX15 P16050 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6287814 0.88 HDAC1 (0.50) KDM4EALDH1A1GAACASP1MAPT
SCHEMBL6290828 0.86 CASP1 (0.51) KDM4EALDH1A1GAACASP1MAPT
SCHEMBL6287887 0.85 HDAC1 (0.59) KDM4EGAAMAPTHDAC1NTRK1
SCHEMBL6290656 0.85 HDAC1 (0.48) KDM4EALDH1A1GAACASP1MAPT
SCHEMBL6286718 0.85 HDAC1 (0.50) KDM4EALDH1A1GAACASP1MAPT
SCHEMBL6290235 0.84 HDAC1 (0.56) KDM4EALDH1A1GAACASP1MAPT
SCHEMBL6290839 0.84 HDAC1 (0.56) KDM4EALDH1A1GAACASP1MAPT
SCHEMBL6287331 0.83 HDAC1 (0.53) KDM4EALDH1A1GAACASP1MAPT
SCHEMBL6285395 0.83 HDAC1 (0.51) KDM4EALDH1A1GAACASP1MAPT
SCHEMBL7037694 0.83 HDAC1 (0.51) KDM4EALDH1A1GAACASP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK KDM4E 2972/4885ALDH1A1 2042/4885GAA 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.